These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas. Leblay N; Leprêtre F; Le Stang N; Gautier-Stein A; Villeneuve L; Isaac S; Maillet D; Galateau-Sallé F; Villenet C; Sebda S; Goracci A; Byrnes G; McKay JD; Figeac M; Glehen O; Gilly FN; Foll M; Fernandez-Cuesta L; Brevet M J Thorac Oncol; 2017 Apr; 12(4):724-733. PubMed ID: 28034829 [TBL] [Abstract][Full Text] [Related]
3. An asbestos-exposed family with multiple cases of pleural malignant mesothelioma without inheritance of a predisposing BAP1 mutation. Cheung M; Kadariya Y; Pei J; Talarchek J; Facciolo F; Visca P; Righi L; Cozzi I; Testa JR; Ascoli V Cancer Genet; 2015 Oct; 208(10):502-7. PubMed ID: 26364129 [TBL] [Abstract][Full Text] [Related]
4. BAP1 protein is a progression factor in malignant pleural mesothelioma. Arzt L; Quehenberger F; Halbwedl I; Mairinger T; Popper HH Pathol Oncol Res; 2014 Jan; 20(1):145-51. PubMed ID: 23963927 [TBL] [Abstract][Full Text] [Related]
5. Germline mutation of Bap1 accelerates development of asbestos-induced malignant mesothelioma. Xu J; Kadariya Y; Cheung M; Pei J; Talarchek J; Sementino E; Tan Y; Menges CW; Cai KQ; Litwin S; Peng H; Karar J; Rauscher FJ; Testa JR Cancer Res; 2014 Aug; 74(16):4388-97. PubMed ID: 24928783 [TBL] [Abstract][Full Text] [Related]
6. Genomic profiling of malignant peritoneal mesothelioma reveals recurrent alterations in epigenetic regulatory genes BAP1, SETD2, and DDX3X. Joseph NM; Chen YY; Nasr A; Yeh I; Talevich E; Onodera C; Bastian BC; Rabban JT; Garg K; Zaloudek C; Solomon DA Mod Pathol; 2017 Feb; 30(2):246-254. PubMed ID: 27813512 [TBL] [Abstract][Full Text] [Related]
7. Germline mutations in DNA repair genes predispose asbestos-exposed patients to malignant pleural mesothelioma. Betti M; Casalone E; Ferrante D; Aspesi A; Morleo G; Biasi A; Sculco M; Mancuso G; Guarrera S; Righi L; Grosso F; Libener R; Pavesi M; Mariani N; Casadio C; Boldorini R; Mirabelli D; Pasini B; Magnani C; Matullo G; Dianzani I Cancer Lett; 2017 Oct; 405():38-45. PubMed ID: 28687356 [TBL] [Abstract][Full Text] [Related]
8. Germline BAP1 mutations predispose to malignant mesothelioma. Testa JR; Cheung M; Pei J; Below JE; Tan Y; Sementino E; Cox NJ; Dogan AU; Pass HI; Trusa S; Hesdorffer M; Nasu M; Powers A; Rivera Z; Comertpay S; Tanji M; Gaudino G; Yang H; Carbone M Nat Genet; 2011 Aug; 43(10):1022-5. PubMed ID: 21874000 [TBL] [Abstract][Full Text] [Related]
10. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members. Kittaneh M; Berkelhammer C J Transl Med; 2018 Jul; 16(1):194. PubMed ID: 30001711 [TBL] [Abstract][Full Text] [Related]
11. Consensus Report of the 2015 Weinman International Conference on Mesothelioma. Carbone M; Kanodia S; Chao A; Miller A; Wali A; Weissman D; Adjei A; Baumann F; Boffetta P; Buck B; de Perrot M; Dogan AU; Gavett S; Gualtieri A; Hassan R; Hesdorffer M; Hirsch FR; Larson D; Mao W; Masten S; Pass HI; Peto J; Pira E; Steele I; Tsao A; Woodard GA; Yang H; Malik S J Thorac Oncol; 2016 Aug; 11(8):1246-1262. PubMed ID: 27453164 [TBL] [Abstract][Full Text] [Related]
12. Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma. Napolitano A; Pellegrini L; Dey A; Larson D; Tanji M; Flores EG; Kendrick B; Lapid D; Powers A; Kanodia S; Pastorino S; Pass HI; Dixit V; Yang H; Carbone M Oncogene; 2016 Apr; 35(15):1996-2002. PubMed ID: 26119930 [TBL] [Abstract][Full Text] [Related]
13. Differential Susceptibility of Human Pleural and Peritoneal Mesothelial Cells to Asbestos Exposure. Dragon J; Thompson J; MacPherson M; Shukla A J Cell Biochem; 2015 Aug; 116(8):1540-52. PubMed ID: 25757056 [TBL] [Abstract][Full Text] [Related]
14. Animal models of malignant mesothelioma. Kane AB Inhal Toxicol; 2006 Nov; 18(12):1001-4. PubMed ID: 16920675 [TBL] [Abstract][Full Text] [Related]
15. Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. Ohar JA; Cheung M; Talarchek J; Howard SE; Howard TD; Hesdorffer M; Peng H; Rauscher FJ; Testa JR Cancer Res; 2016 Jan; 76(2):206-15. PubMed ID: 26719535 [TBL] [Abstract][Full Text] [Related]
16. Peritoneal mesothelioma: the site of origin matters. Kindler HL Am Soc Clin Oncol Educ Book; 2013; ():182-8. PubMed ID: 23714495 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962 [TBL] [Abstract][Full Text] [Related]
18. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing. Mäki-Nevala S; Sarhadi VK; Knuuttila A; Scheinin I; Ellonen P; Lagström S; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuutila S Lung; 2016 Feb; 194(1):125-35. PubMed ID: 26463840 [TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of multiple primary cancers including synchronous lung adenocarcinoma and bilateral malignant mesotheliomas: Identification of a novel BAP1 germline variant. Shinozaki-Ushiku A; Kohsaka S; Kage H; Oda K; Miyagawa K; Nakajima J; Aburatani H; Mano H; Ushiku T Pathol Int; 2020 Oct; 70(10):775-780. PubMed ID: 32583627 [TBL] [Abstract][Full Text] [Related]
20. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas. Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]